Year |
Citation |
Score |
2020 |
Kevin RC, Vogel R, Doohan P, Berger M, Amminger GP, McGregor IS. A validated method for the simultaneous quantification of CBD, THC, and their metabolites in human plasma, and application to plasma samples from an oral CBD open label trial. Drug Testing and Analysis. PMID 33095968 DOI: 10.1002/dta.2947 |
0.56 |
|
2020 |
Berger M, Li E, Amminger GP. Treatment of social anxiety disorder and attenuated psychotic symptoms with cannabidiol. Bmj Case Reports. 13. PMID 33028567 DOI: 10.1136/bcr-2020-235307 |
0.56 |
|
2020 |
McLaverty A, Allott KA, Berger M, Hester R, McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, et al. Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis. Early Intervention in Psychiatry. PMID 32893462 DOI: 10.1111/eip.13025 |
0.56 |
|
2020 |
Berger M, Nelson B, Markulev C, Yuen HP, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, et al. Corrigendum: Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial. Frontiers in Psychiatry. 11: 514. PMID 32595533 DOI: 10.3389/fpsyt.2020.00514 |
0.56 |
|
2020 |
Berger M, Amminger GP, McDermott R, Guest PC, Sarnyai Z. Testing the Effects of Dietary Seafood Consumption on Depressive Symptoms. Methods in Molecular Biology (Clifton, N.J.). 2138: 233-242. PMID 32219752 DOI: 10.1007/978-1-0716-0471-7_15 |
1 |
|
2019 |
Hartmann JA, Schmidt SJ, McGorry PD, Berger M, Berger GE, Chen EYH, de Haan L, Hickie IB, Lavoie S, Markulev C, Mossaheb N, Nieman DH, Nordentoft M, Polari A, Riecher-Rössler A, et al. Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial. Behaviour Research and Therapy. 124: 103527. PMID 31790853 DOI: 10.1016/j.brat.2019.103527 |
0.56 |
|
2019 |
Amminger GP, Nelson B, Markulev C, Yuen HP, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, et al. The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis. Biological Psychiatry. PMID 31690495 DOI: 10.1016/j.biopsych.2019.08.030 |
0.56 |
|
2019 |
Alqarni A, Mitchell TW, McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, et al. Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis. Schizophrenia Research. PMID 31606244 DOI: 10.1016/j.schres.2019.08.033 |
0.56 |
|
2019 |
Alqarni A, Mitchell TW, McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, et al. Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people. Schizophrenia Research. PMID 31301881 DOI: 10.1016/j.schres.2019.06.020 |
0.56 |
|
2019 |
Berger M, Nelson B, Markulev C, Yuen HP, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, et al. Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial. Frontiers in Psychiatry. 10: 393. PMID 31244693 DOI: 10.3389/fpsyt.2019.00393 |
0.56 |
|
2019 |
Berger M, Taylor S, Harriss L, Campbell S, Thompson F, Jones S, Sushames A, Amminger GP, Sarnyai Z, McDermott R. Hair cortisol, allostatic load, and depressive symptoms in Australian Aboriginal and Torres Strait Islander people. Stress (Amsterdam, Netherlands). 1-9. PMID 30835590 DOI: 10.1080/10253890.2019.1572745 |
1 |
|
2018 |
Berger M, Lavoie S, McGorry PD, Nelson B, Markulev C, Yuen HP, Schaefer M, Sarnyai Z, Amminger GP. Relationship between allostatic load and clinical outcomes in youth at ultra-high risk for psychosis in the NEURAPRO study. Schizophrenia Research. PMID 30340917 DOI: 10.1016/j.schres.2018.10.002 |
1 |
|
2018 |
Harriss LR, Kyle M, Connolly K, Murgha E, Bulmer M, Miller D, Munn P, Neal P, Pearson K, Walsh M, Campbell S, Berger M, McDermott R, McDonald M. Screening for depression in young Indigenous people: building on a unique community initiative. Australian Journal of Primary Health. PMID 30089528 DOI: 10.1071/PY18006 |
0.32 |
|
2018 |
Berger M, Juster RP, Westphal S, Amminger GP, Bogerts B, Schiltz K, Bahn S, Steiner J, Sarnyai Z. Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis. Psychoneuroendocrinology. 90: 35-42. PMID 29427955 DOI: 10.1016/j.psyneuen.2018.02.001 |
1 |
|
2017 |
Berger ME, Smesny S, Kim SW, Davey CG, Rice S, Sarnyai Z, Schlögelhofer M, Schäfer MR, Berk M, McGorry PD, Amminger GP. Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study. Translational Psychiatry. 7: e1220. PMID 28850110 DOI: 10.1038/tp.2017.190 |
1 |
|
2017 |
Mossaheb N, Schäfer MR, Schlögelhofer M, Klier CM, Smesny S, McGorry PD, Berger M, Amminger GP. Predictors of longer-term outcome in the Vienna omega-3 high-risk study. Schizophrenia Research. PMID 28823721 DOI: 10.1016/j.schres.2017.08.010 |
0.56 |
|
2017 |
Steiner J, Berger M, Guest PC, Dobrowolny H, Westphal S, Schiltz K, Sarnyai Z. Assessment of Insulin Resistance Among Drug-Naive Patients With First-Episode Schizophrenia in the Context of Hormonal Stress Axis Activation. Jama Psychiatry. PMID 28724123 DOI: 10.1001/jamapsychiatry.2017.1983 |
1 |
|
2017 |
Langbein K, Schmidt U, Schack S, Biesel NJ, Rudzok M, Amminger GP, Berger M, Sauer H, Smesny S. State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study. Schizophrenia Research. PMID 28602647 DOI: 10.1016/j.schres.2017.06.007 |
0.56 |
|
2017 |
Amminger GP, Berger M, Rice SM, Davey CG, Schäfer MR, McGorry PD. Novel biotherapies are needed in youth mental health. Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists. 25: 117-120. PMID 28375061 DOI: 10.1177/1039856217698237 |
0.56 |
|
2017 |
Berger M, Leicht A, Slatcher A, Kraeuter AK, Ketheesan S, Larkins S, Sarnyai Z. Cortisol Awakening Response and Acute Stress Reactivity in First Nations People. Scientific Reports. 7: 41760. PMID 28139727 DOI: 10.1038/srep41760 |
1 |
|
2017 |
Smesny S, Milleit B, Schaefer MR, Hesse J, Schlögelhofer M, Langbein K, Hipler UC, Berger M, Cotter DR, Sauer H, McGorry PD, Amminger GP. Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 study. Schizophrenia Research. PMID 28126360 DOI: 10.1016/j.schres.2017.01.026 |
0.56 |
|
2016 |
Berger M, Kraeuter AK, Romanik D, Malouf P, Amminger GP, Sarnyai Z. Cortisol Awakening Response in Patients with Psychosis: Systematic Review and Meta-Analysis. Neuroscience and Biobehavioral Reviews. PMID 27229759 DOI: 10.1016/j.neubiorev.2016.05.027 |
1 |
|
2015 |
Sarnyai Z, Berger M, Jawan I. Allostatic load mediates the impact of stress and trauma on physical and mental health in Indigenous Australians. Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists. PMID 26646603 DOI: 10.1177/1039856215620025 |
1 |
|
2015 |
Berger M, Juster RP, Sarnyai Z. Mental health consequences of stress and trauma: allostatic load markers for practice and policy with a focus on Indigenous health. Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists. PMID 26432654 DOI: 10.1177/1039856215608281 |
1 |
|
2015 |
Berger M, Sarnyai Z. "More than skin deep": stress neurobiology and mental health consequences of racial discrimination. Stress (Amsterdam, Netherlands). 18: 1-10. PMID 25407297 DOI: 10.3109/10253890.2014.989204 |
1 |
|
Show low-probability matches. |